News
SmartCella granted new European patent for the Extroducer delivery platform
XyloCor Therapeutics and SmartCella Enter into License Agreement for Use of the Extroducer Infusion Catheter System to Administer Novel Gene Therapy XC001 to the Heart
SmartCella raises EUR 50 million to accelerate growth and commercialization
Senior life science and medical specialists join SmartCella’s Board of Directors
SmartCella strengthens team with Dr. Ricardo Baptista as CTO
CEO comments on the full year of 2023
SmartCella AB appoints Oskar Steneryd as new CFO
SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies
SmartCella strengthens team by recruiting Dr. Nina Bauer as Chief Business Officer
Q2 update on the SmartCella family
Let’s pioneer the future of targeted therapies together